
Sickening
How Big Pharma Broke American Health Care and How We Can Repair It
HarperCollins · Print & ebook · February 21, 2023
The inside story of how Big Pharma’s relentless pursuit of ever-higher profits corrupts medical knowledge—misleading doctors, misdirecting American health care, and harming our health.
We earn from qualifying purchases.
- Who it’s for
- Follow how drug-industry incentives can distort medical knowledge and steer American health care.
- Genres
- Health Policy, Health Care Policy, Pharma & Biotech Industry
- Published
- HarperCollins, February 21, 2023
Nearest books
Matched by what the books are about, then ordered by what their readers also loved.
DoctoredCharles Piller69% matchShares Health Policy and Pharma & Biotech Industry
Lies I Taught in Medical SchoolRobert Lufkin MD, Jim Meskimen61% match
Dirty GenesDr. Ben Lynch, Ben Lynch54% match
Gut CheckSteven R. Gundry MD, Steven R. Gundry55% match
Good EnergyCasey Means MD, Calley Means54% match
Start with three books, and this one can be the first.
Members get a new edition every morning: a route out from their books to essays, research and talks, with the reason for each.
Start with this bookAbout this book
The inside story of how Big Pharma’s relentless pursuit of ever-higher profits corrupts medical knowledge—misleading doctors, misdirecting American health care, and harming our health. The United States spends an excess $1.5 trillion annually on health care compared to other wealthy countries—yet the amount of time that Americans live in good health ranks a lowly 68th in the world.
Continue reading
At the heart of the problem is Big Pharma, which funds most clinical trials and therefore controls the research agenda, withholds the real data from those trials as corporate secrets, and shapes most of the information relied upon by health care professionals. In this no-holds-barred exposé, Dr. John Abramson—one of the foremost experts on the drug industry’s deceptive tactics—combines patient stories with what he learned during many years of serving as an expert in national drug litigation to reveal the tangled web of financial interests at the heart of the dysfunction in our health-care system. For example, one of pharma’s best-kept secrets is that the peer reviewers charged with ensuring the accuracy and completeness of the clinical trial reports published in medical journals do not even have access to complete data and must rely on manufacturer-influenced summaries. Likewise for the experts who write the clinical practice guidelines that define our standards of care. The result of years of research and privileged access to the inner workings of the U.S. medical-industrial complex, Sickening shines a light on the dark underbelly of American health care—and presents a path toward genuine reform.
Following the Incentives
Follow how drug-industry incentives can distort medical knowledge and steer American health care.
Come here for
- A close look at pharma’s influence on clinical research
- Patient stories alongside the financial interests shaping care
Expect
- A detailed critique grounded in clinical-trial reporting
- An account linking patient experience to calls for reform
Where it sits
| Health Policy | 51% |
|---|---|
| Pharma & Biotech Industry | 42% |
| Health Care Policy | 30% |
Percentages are BookFrontier’s reading of the book.
Publisher categories
- Healthcare Issues
- Vaccinations
- Diagnosis
- Health Care Delivery
Show all 8 publisher categories
- Health Policy
- Pharmacology
- Public Health
- Physician Practice
- Authors
- John Abramson
- Publisher
- HarperCollins
- Published
- February 21, 2023
- Format
- Print & ebook
- Reading lane
- Healthcare Issues